NeuroOne Medical Technologies Corporation (NMTC) News
Follow NeuroOne Medical Technologies Corporation (NMTC) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 5 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
H
NeuroOne Medical Technologies Reports Preliminary Q4 Sales ~$3.8M, Up 38.4% YoY; Sees FY26 Sales Of ~$10.5M, Up 15.6% YoY; Includes September Purchase Order Of $4.5M
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC ) ("NeuroOne" or the "Company"), a medical technology company dedicated to transforming the surgical diagnosis and treatment of neurological disorders, today announ
LIVE | Oct 05, 2026, 01:21 PM UTC
M
NeuroOne reports preliminary Q4 product revenue growth of 38.4%
NeuroOne said preliminary fiscal Q4 product revenue grew 38.4% and that it secured a record $4.5 million purchase order.
EQUITY | Oct 05, 2026, 01:18 PM UTC
L
NMTC - NeuroOne® Expands U.S. Commercialization of FDA -Cleared OneRF® Trigeminal Nerve Ablation System with New Southern California Distribution Agreement
NMTC - NeuroOne® Expands U.S. Commercialization of FDA -Cleared OneRF® Trigeminal Nerve Ablation System with New Southern California Distribution Agreement
REGULATION | Sep 17, 2026, 01:05 PM UTC
L
Neuroone Medical files update on Stereoced robotic drug delivery
Neuroone Medical Technologies Corp announced successful robotic-assisted drug delivery using its Stereoced platform and said it was covered in an SEC filing.
REGULATION | Aug 27, 2026, 01:29 PM UTC
L
NeuroOne reports successful large-animal StereoCED procedures
NeuroOne says it completed successful large-animal StereoCED procedures and expects related revenue in Q4 2026.
EARNINGS | Aug 27, 2026, 01:13 PM UTC